PropertyValue
?:abstract
  • • Although small with short-term data, our series reports a translational experience of a cardiovascular department facing MACE in COVID-19 patients being acute arterial events the new insight into this COVID-19 pandemic. • COVID-19 infection may trigger a hypercoagulable status leading to challenging MACE and is associated with high mortality rate. • COVID-19 patient with MACE should be treated with both ventilator support, extensive operative cardiac and peripheral revascularization, and the adjunct of heparin which provides better survival chance independently of the infection-related drug treatment.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.thromres.2020.10.038
?:doi
?:journal
  • Thromb_Res
?:license
  • els-covid
?:pdf_json_files
  • document_parses/pdf_json/733849e0cb36dbc2e5509ceaf745623464d5f818.json
?:pmcid
?:pmid
?:pmid
  • 33260043.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Major cardiovascular events in patients with Coronavirus Disease 2019: experience of a cardiovascular Department of Northern Italy
?:type
?:year
  • 2020-11-06

Metadata

Anon_0  
expand all